Kyeong-Ho Min
Fortuna: 651 852 $ al 30/06/2026
Fortuna: 651 852 $ al 30/06/2026
Kyeong-Ho Min currently holds the positions of Director, Vice President & Head-Production at EuBiologics Co., Ltd. since 2010, Professor at Tech University of Korea, and Head-Process Management at Korea Biotechnology Commercialization Center since 2015.
The education history includes a doctorate degree from Inha University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EUBIOLOGICS CO., LTD. 0,32 % | 31/12/2025 | 116.753 ( 0,32 % ) | 651 852 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EUBIOLOGICS CO., LTD. | Director/Miembro de la Junta | 01/12/2010 |
Korea Biotechnology Commercialization Center | Corporate Officer/Principal | - |
Tech University of Korea
Tech University of Korea Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Inha University
Inha University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EuBiologics Co., Ltd.
EuBiologics Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceuticals products | Health Technology |
Korea Biotechnology Commercialization Center | |
Tech University of Korea
Tech University of Korea Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.